Fig. 3

Risk of COVID-19 related complications by cardiovascular risk group. A Any cardiovascular complications. B Non-arrhythmia related cardiovascular complications. C Venous thromboembolism. aOR, adjusted odds ratio; CV, cardiovascular; CVD, cardiovascular disease; DVT, deep vein thrombosis; PE, pulmonary embolism; MI, myocardial infarction; VTE, venous thromboembolism. Each model is adjusted for the variables listed, as well as age, sex, ethnicity, non-cardiac comorbidities (asthma, COPD, chronic renal failure, pulmonary embolism, DVT) and medications (ACEI or ARB, aldosterone receptor antagonists, beta-blockers, calcium channel blockers, loop diuretics, statins, anticoagulants, antiplatelet agents, metformin, sulphonylureas, SGLT2 inhibitors, DPP4 inhibitors, thiazolidinediones, GLP1 receptor agonists, insulin)